• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

面肩肱型肌营养不良症中的限制性肺受累

Restrictive lung involvement in facioscapulohumeral muscular dystrophy.

作者信息

Scully Michele A, Eichinger Katy J, Donlin-Smith Colleen M, Tawil Rabi, Statland Jeffery M

机构信息

Department of Neurology, University of Rochester Medical Center, Box 673, 601 Elmwood Avenue, Rochester, New York, 14642.

出版信息

Muscle Nerve. 2014 Nov;50(5):739-43. doi: 10.1002/mus.24218. Epub 2014 Sep 29.

DOI:10.1002/mus.24218
PMID:24639337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4142113/
Abstract

INTRODUCTION

Few studies have evaluated the frequency or predisposing factors for respiratory involvement in facioscapulohumeral muscular dystrophy type 1 (FSHD1) and type 2 (FSHD2).

METHODS

We performed a prospective cross-sectional observational study of 61 genetically confirmed FSHD participants (53 FSHD1 and 8 FSHD2). Participants underwent bedside pulmonary function testing in sitting and supine positions, a standard clinical history and physical assessment, and manual muscle testing.

RESULTS

Restrictive respiratory involvement was suggested in 9.8% (95% confidence interval 2.4-17.3): 7.5% FSHD1 and 25.0% FSHD2 (P = 0.17). Participants with testing suggestive of restrictive lung involvement (n = 6) were more severely affected (P = 0.005), had weaker hip flexion (P = 0.0007), and were more likely to use a wheelchair (P = 0.01).

CONCLUSIONS

Restrictive respiratory involvement should be considered in all moderate to severely affected FSHD patients with proximal lower extremity weakness. The higher frequency of restrictive lung disease in FSHD2 seen here requires confirmation in a larger cohort of FSHD2 patients.

摘要

引言

很少有研究评估1型面肩肱型肌营养不良症(FSHD1)和2型面肩肱型肌营养不良症(FSHD2)患者呼吸系统受累的频率或诱发因素。

方法

我们对61名基因确诊的FSHD患者(53例FSHD1和8例FSHD2)进行了一项前瞻性横断面观察研究。参与者接受了坐位和仰卧位的床边肺功能测试、标准的临床病史和体格检查以及徒手肌力测试。

结果

9.8%的患者提示存在限制性呼吸受累(95%置信区间2.4 - 17.3):FSHD1为7.5%,FSHD2为25.0%(P = 0.17)。肺功能测试提示存在限制性肺受累的参与者(n = 6)病情更严重(P = 0.005),髋关节屈曲力量更弱(P = 0.0007),且更有可能使用轮椅(P = 0.01)。

结论

对于所有有近端下肢无力的中重度FSHD患者,均应考虑存在限制性呼吸受累。此处观察到的FSHD2患者中限制性肺病的较高发生率需要在更大规模的FSHD2患者队列中得到证实。

相似文献

1
Restrictive lung involvement in facioscapulohumeral muscular dystrophy.面肩肱型肌营养不良症中的限制性肺受累
Muscle Nerve. 2014 Nov;50(5):739-43. doi: 10.1002/mus.24218. Epub 2014 Sep 29.
2
FSHD1 and FSHD2 form a disease continuum.面肩肱型肌营养不良症 1 型和 2 型构成疾病连续统。
Neurology. 2019 May 7;92(19):e2273-e2285. doi: 10.1212/WNL.0000000000007456. Epub 2019 Apr 12.
3
Clinical features of facioscapulohumeral muscular dystrophy 2.面肩肱型肌营养不良 2 型的临床特征。
Neurology. 2010 Oct 26;75(17):1548-54. doi: 10.1212/WNL.0b013e3181f96175.
4
[Facioscapulohumeral muscular dystrophy type 2].2型面肩肱型肌营养不良症
Rev Neurol (Paris). 2013 Aug-Sep;169(8-9):564-72. doi: 10.1016/j.neurol.2013.02.004. Epub 2013 Aug 20.
5
Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy.面肩肱型肌营养不良症活动型和非活动型患者的呼吸受累情况
J Neurol. 2017 Jun;264(6):1271-1280. doi: 10.1007/s00415-017-8525-9. Epub 2017 May 26.
6
Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2.面肩肱型肌营养不良症中的腿部肌肉受累情况:1型与2型面肩肱型肌营养不良症的比较
Eur Neurol. 2017;77(1-2):32-39. doi: 10.1159/000452763. Epub 2016 Nov 18.
7
Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms.1 型面肩肱型肌营养不良症患者参与英国 FSHD 登记处,可以根据自我报告的症状分为 4 种类型。
Neuromuscul Disord. 2020 Apr;30(4):315-328. doi: 10.1016/j.nmd.2020.03.001. Epub 2020 Mar 12.
8
Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging.磁共振成像对 2 型面肩肱型肌营养不良症的深度表型分析。
Eur J Neurol. 2020 Dec;27(12):2604-2615. doi: 10.1111/ene.14446. Epub 2020 Aug 14.
9
Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: Update of the 2012 guidelines.面肩肱型肌营养不良症基因诊断的最佳实践指南:2012 年指南更新。
Clin Genet. 2024 Jul;106(1):13-26. doi: 10.1111/cge.14533. Epub 2024 Apr 29.
10
MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.MRI作为面肩肱型肌营养不良症的疗效指标:45例患者的1年随访
J Neurol. 2017 Mar;264(3):438-447. doi: 10.1007/s00415-016-8361-3. Epub 2016 Dec 20.

引用本文的文献

1
Double trouble: a comprehensive study into unrelated genetic comorbidities in adult patients with Facioscapulohumeral Muscular Dystrophy Type I.双重麻烦:对成年I型面肩肱型肌营养不良患者无关基因共病的综合研究
Eur J Hum Genet. 2025 Jan 7. doi: 10.1038/s41431-024-01770-0.
2
Hereditary Neuromuscular Disorders in Reproductive Medicine.遗传性神经肌肉疾病与生殖医学。
Genes (Basel). 2024 Oct 30;15(11):1409. doi: 10.3390/genes15111409.
3
Respiratory function and evaluation in individuals with facioscapulohumeral muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking and Research Network.肌肉萎缩症监测、追踪与研究网络中面肩肱型肌营养不良患者的呼吸功能及评估
Neuromuscul Disord. 2025 Jan;46:105240. doi: 10.1016/j.nmd.2024.105240. Epub 2024 Nov 9.
4
French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD).法国面肩肱型肌营养不良症(FSHD)诊断和治疗国家方案。
J Neurol. 2024 Sep;271(9):5778-5803. doi: 10.1007/s00415-024-12538-3. Epub 2024 Jul 2.
5
Deciphering D4Z4 CpG methylation gradients in fascioscapulohumeral muscular dystrophy using nanopore sequencing.使用纳米孔测序技术解析面肩肱型肌营养不良症中D4Z4 CpG甲基化梯度
Genome Res. 2023 Sep;33(9):1439-1454. doi: 10.1101/gr.277871.123. Epub 2023 Oct 5.
6
Deciphering D4Z4 CpG methylation gradients in fascioscapulohumeral muscular dystrophy using nanopore sequencing.利用纳米孔测序解读面肩肱型肌营养不良症中D4Z4 CpG甲基化梯度
bioRxiv. 2023 Mar 29:2023.02.17.528868. doi: 10.1101/2023.02.17.528868.
7
Long-Term Systemic Treatment of a Mouse Model Displaying Chronic FSHD-like Pathology with Antisense Therapeutics That Inhibit Expression.用抑制表达的反义疗法对表现出慢性面肩肱型肌营养不良症(FSHD)样病理的小鼠模型进行长期全身治疗。
Biomedicines. 2022 Jul 7;10(7):1623. doi: 10.3390/biomedicines10071623.
8
Long-term follow-up of respiratory function in facioscapulohumeral muscular dystrophy.面肩肱型肌营养不良症患者呼吸功能的长期随访。
J Neurol. 2022 Jul;269(7):3682-3689. doi: 10.1007/s00415-022-10990-7. Epub 2022 Feb 11.
9
Genetic Approaches for the Treatment of Facioscapulohumeral Muscular Dystrophy.治疗面肩肱型肌营养不良症的基因方法。
Front Pharmacol. 2021 Mar 12;12:642858. doi: 10.3389/fphar.2021.642858. eCollection 2021.
10
Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update.面肩肱型肌营养不良症:遗传学、基因激活及近期治疗方法的下游信号转导:最新进展。
Orphanet J Rare Dis. 2021 Mar 12;16(1):129. doi: 10.1186/s13023-021-01760-1.

本文引用的文献

1
Respiratory pattern in an adult population of dystrophic patients.成人型营养不良患者群体的呼吸模式。
J Neurol Sci. 2011 Jul 15;306(1-2):54-61. doi: 10.1016/j.jns.2011.03.045. Epub 2011 May 6.
2
Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.面肩肱型肌营养不良症和 DUX4:打破沉默。
Trends Mol Med. 2011 May;17(5):252-8. doi: 10.1016/j.molmed.2011.01.001. Epub 2011 Feb 1.
3
Clinical features of facioscapulohumeral muscular dystrophy 2.面肩肱型肌营养不良 2 型的临床特征。
Neurology. 2010 Oct 26;75(17):1548-54. doi: 10.1212/WNL.0b013e3181f96175.
4
A unifying genetic model for facioscapulohumeral muscular dystrophy.面肩肱型肌营养不良症的统一遗传模型。
Science. 2010 Sep 24;329(5999):1650-3. doi: 10.1126/science.1189044. Epub 2010 Aug 19.
5
Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample.面肩肱型肌营养不良症:意大利东北部人群样本的流行病学和分子研究
Clin Genet. 2009 Jun;75(6):550-5. doi: 10.1111/j.1399-0004.2009.01158.x. Epub 2009 Mar 23.
6
Lung and respiratory muscle function in facioscapulohumeral muscular dystrophy.面肩肱型肌营养不良症患者的肺和呼吸肌功能
Muscle Nerve. 2009 Jun;39(6):729-34. doi: 10.1002/mus.21261.
7
Interpretative strategies for lung function tests.肺功能测试的解读策略。
Eur Respir J. 2005 Nov;26(5):948-68. doi: 10.1183/09031936.05.00035205.
8
Ventilatory support in facioscapulohumeral muscular dystrophy.面肩肱型肌营养不良症的通气支持
Neurology. 2004 Jul 13;63(1):176-8. doi: 10.1212/01.wnl.0000133126.86377.e8.
9
Spirometry in normal subjects in sitting, prone, and supine positions.正常受试者在坐位、俯卧位和仰卧位时的肺量测定。
Respir Care. 2000 Apr;45(4):407-10.
10
Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype.面肩肱型肌营养不良症的分子诊断进展以及4q35位点KpnI重复序列数量与临床表型的相关性
Ann Neurol. 1999 Jun;45(6):751-7. doi: 10.1002/1531-8249(199906)45:6<751::aid-ana9>3.0.co;2-m.